Today news
About the same in other media
Lonza to acquire biologics site from Roche in U.S. for $1.2 billion
Reading now: 174
investing.comZURICH (Reuters) — Swiss contract drug manufacturer Lonza said on Wednesday it has signed an agreement to acquire the Genentech manufacturing facility in Vacaville, California, from drugmaker Roche for $1.2 billion in cash.
Lonza plans to invest around 500 million Swiss francs ($562.30 million) to upgrade the facility and enhance capabilities at the site to accommodate the next generation of mammalian biologics therapies, the company said in a statement.
($1 = 0.8892 Swiss francs)
Read more on investing.comAbout this in other media
Google to purge billions of files containing personal data in settlement of Chrome privacy case abcnews.go.com /7 months ago
California's $20 minimum wage for fast-food workers goes into effect foxbusiness.com /7 months ago
British-American star Chance Perdomo passes away at 27 from motor cycle accident economictimes.indiatimes.com /7 months ago
Show more
The website fvbb.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
